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Abstract 1 
Ross River virus (RRV) is a mosquito-borne member of the genus Alphavirus that causes 2 
epidemic polyarthritis (EPA) in humans, costing the Australian health system at least US$10 3 
million dollars annually.  Recent progress in RRV vaccine development requires accurate 4 
assessments of RRV genetic diversity and evolution, particularly as they may affect the utility of 5 
future vaccination.  In this study, we provide novel RRV genome sequences and investigate the 6 
evolutionary dynamics of RRV from time-structured E2 gene data sets.  Our analysis indicates 7 
that although RRV evolves at similar rates to other alphaviruses (mean evolutionary rate of ~8 x 8 
10-4 nucleotide substitutions per site per year), the relative genetic diversity of RRV has been 9 
continuously low through time, possibly as a result of purifying selection imposed by replication 10 
in a wide range of natural host and vector species.  Together, these findings suggest that 11 
vaccination against RRV is unlikely to result in the rapid antigenic evolution that could 12 
compromise the future efficacy of current RRV vaccines. 13 
14 
 3
Introduction 1 
Ross River virus (RRV) is an Alphavirus that infects a wide range of vertebrate hosts including 2 
marsupials, equids, rodents, birds, and fruit bats and has multiple mosquito vectors, including 3 
several Aedes species (reviewed in Russell, 2002).  Of the natural hosts, only humans and 4 
horses are known to develop symptoms (Doherty et al., 1963; Doherty et al., 1972; Azuolas et 5 
al., 2003).  The disease in humans is known as epidemic polyarthritis (EPA) (Shope & 6 
Anderson, 1960) and is characterised by polyarthralgia in the small joints, principally of the 7 
hands and feet, as well as fever, rash and a range of other non-specific signs and symptoms.  8 
Patients may be incapacitated for several weeks after infection, but symptoms diminish in 9 
severity in the ensuing 30-40 weeks, leading to a full recovery.  As many as ~7800 cases are 10 
reported annually from Australia (Australian Department of Health and Ageing, 2009) and an 11 
epidemic of RRV infection in the Pacific in 1979 and 1980 resulted in tens of thousands of 12 
clinical infections (Aaskov et al., 1981; Rosen et al., 1981; Tesh et al., 1981).  Importantly, the 13 
Pacific epidemic of 1979-1980 strongly suggests that RRV is not dependent on purely sylvatic 14 
transmission cycles, and that urban transmission cycles are both possible and expected. 15 
Recently, there has been considerable interest in developing a vaccine against RRV 16 
infection (Yu & Aaskov, 1994; Aaskov et al., 1997; Kistner et al., 2007) because there is no cure 17 
for EPA, because RRV infections appear to confer lifelong immunity against a second clinical 18 
infection (Fraser, 1986), and because EPA has been estimated to cost the Australian health 19 
system more than US$10 million annually in direct medical costs (Aaskov et al., 1998) with 20 
millions more spent on mosquito control.  Effective vaccination, whether by live attenuated virus 21 
or inactivated virus, such as the formaldehyde inactivated virus vaccine currently in 22 
development (Kistner et al. 2007), requires that circulating viruses are antigenically similar to the 23 
vaccine strain.  However, this might not be the case over time if the virus population undergoes 24 
rapid antigenic evolution, so that continual vaccine escape mutations allow only transient cross-25 
immunity, as has been documented for human influenza A virus (e.g., Fitch et al., 1991; 26 
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Rambaut et al., 2008).  Although such powerful and continuous positive selection has not been 1 
identified in vector-borne RNA viruses, which also seem subject to relatively strong selective 2 
constraints (Woelk & Holmes, 2002), instances of periodic adaptive evolution have been 3 
recorded in the mosquito-vectored dengue viruses (Bennett et al., 2003; Twiddy et al., 2002), 4 
which infect humans and exists  primarily in urban cycles of transmission.  This raises the 5 
possibility that positive selection could affect the antigenic profile of vector-borne RNA viruses 6 
with largely urban transmission cycles, even though these tend to be subject to greater selective 7 
constraints than directly transmitted viruses such as influenza A (Woelk & Holmes, 2002).  8 
Antigenic drift caused by positive selection also requires sufficient viral diversity in the host 9 
population.  This can be generated either by high rates of nucleotide substitution (themselves a 10 
product of high background mutation rates) or by large effective population sizes.  In addition, 11 
understanding how RRV might respond to future vaccination pressures also requires knowledge 12 
of the fitness distribution of viral mutations.  This may be manifest as the relative numbers of 13 
nonsynonymous and synonymous substitutions per site and the extent of viral gene flow among 14 
geographic regions, as natural selection is expected to be most pronounced in spatially well 15 
mixed populations. 16 
Although intensive molecular evolutionary studies have been performed on a number of 17 
alphaviruses, most recently Chikungunya virus (Cherian et al., 2009), no such studies have 18 
been performed on RRV.  Indeed, there is only limited information on the genetic variability of 19 
RRV (Sammels et al., 1995), with only two RRV genomes sequenced and available (strains 20 
NB5092 and T48; Faragher et al., 1988).  While both strains were recovered from mosquitoes 21 
and adapted to grow in the brains of suckling mice (Faragher et al., 1988), the pedigree of the 22 
NB5092 strain is uncertain (Gard et al., 1973).  Herein, we both provide new genome sequences 23 
of RRV recovered from multiple host species (birds, marsupials, and a human) and estimate the 24 
evolutionary and epidemiological dynamics of gene sequences from 61 isolates of RRV 25 
incorporating time-structured data. 26 
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 1 
Materials and Methods 2 
Isolation and nucleotide sequencing of novel RRV genomes. 3 
Complete RRV genomes were sequenced from viruses recovered from mosquitoes (T48), 4 
wallabies (8961W, 9057W), birds (2975B, 2982B, 3078B), and from a human EPA patient 5 
(QML1).  RNA was extracted from RRV in the supernatant of infected cultures of Vero cells with 6 
QIAamp viral RNA minicolumns (Qiagen, Hilden, Germany), according to the manufacturer's 7 
instructions.  The RNA was reverse transcribed with Superscript III reverse transcriptase 8 
(Invitrogen, U.S.A) and random hexanucleotide primers (Boehringer, Mannheim, Germany) or 9 
with primers listed in Table S1 (available online as supplementary data).  Seven overlapping 10 
fragments (nucleotides 1-1562, 1241-3441, 2944-4809, 4581-6406, 6216-9045, 7939-9537, 11 
9517-11657) of the resultant cDNA were amplified using a mixture of Taq and Pwo polymerases 12 
(Expand Long Template DNA polymerase; Roche) and virus-specific primers (Table S1).  The 13 
PCR product was analysed in 1.5% w/v agarose-Tris-acetate-EDTA gels, and bands of cDNA of 14 
interest were recovered and purified with QIAquick gel extraction kits (Qiagen) according to the 15 
manufacturer's instructions.  The cDNA was sequenced at the Australian Genome Research 16 
Facility (AGRF, Brisbane) using di-deoxy dye termination technology (Applied Biosystems). 17 
Determination of the nucleotide sequences of the 5’ ends of the genome was performed 18 
using a strategy for the Rapid Amplification of cDNA Ends (RACE) described previously (Tillett 19 
et al., 2000).  Briefly, cDNA from the RRV isolates was prepared from RNA using 30pmol of 20 
primer cP370 and Superscript III reverse transcriptase as described above.  The cDNA was 21 
treated with 1 unit of RNase H (Roche) for 20mins at 37◦C prior to purification using a High Pure 22 
column (Roche).  cDNA was ligated to an oligonucleotide adaptor DT88  (5’-23 
GAAGAGAAGGTGGAAATGGCGTTTGG-3’), which contained a 3’dideoxy-A and a 24 
phosphorylated 5’ terminus, using T4 RNA ligase.  The resultant adaptor-ligated cDNA was 25 
amplified using primer PDT88 (5’CCAAAACGCCATTTCCACCTTCTCTTC3’ which was 26 
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complementary to the adaptor and virus-specific primer cP114) and the PCR conditions 1 
described above.  PCR product was analysed and purified from a 2.5% TAE gel and ligated into 2 
pGEM-T Easy plasmids using T4 DNA ligase (Promega).  Escherichia coli DH5 cells were 3 
transformed with vector according to the manufacturer's instructions (Invitrogen) and plasmids 4 
were purified from individual bacterial colonies which grew on Luria-Bertani agar supplemented 5 
with 100 µg of ampicillin/ml, 0.5 mM isopropyl-ß-D-thiogalactopyranoside (IPTG), and 80 µg of 6 
5-bromo-4-chloro-3-indoyl-ß-D-galactosidase/ml, using QIAprep Miniprep kits (Qiagen).  Viral 7 
cDNA inserts in plasmids were sequenced at the A.G.R.F. (above) using plasmid-specific 8 
primers.  The nucleotide sequences of the 3’ ends of the genomes of RRV T48, QML1, 2982B, 9 
2975B, 3078B, 8961W and 9057W were determined using a similar RACE strategy.  However, 10 
adaptor cDNA, DT88, was ligated to the 3’ end of the RNA using T4 RNA ligase prior to the 11 
production of cDNA using the primer PDT88 and superscript III reverse transcriptase as above.  12 
PCR amplification of the resultant cDNA was performed using the primers P11374 and PDT88 13 
and the resultant ds-cDNA was purified and sequenced as above.  The ds-cDNA from RRV 14 
9057W and T48 also was ligated into pGEM-T Easy plasmids, and sequenced as described 15 
above.  These novel genome sequences have been deposited in GenBank under accession 16 
numbers [submission to GenBank in progress], and the details of the novel RRV isolates are 17 
available online as Table S2.   18 
 19 
Sequence Alignments  20 
The seven novel RRV genome sequences and one additional RRV genome sequence taken 21 
from GenBank (NB5092) were aligned using ClustalX (Thompson et al., 1994) and the resulting 22 
alignment of 11,900 nucleotide positions was edited by hand to maintain reading frame integrity.  23 
A second data set was assembled from the envelope glycoprotein (E2) genes of the eight 24 
viruses for which the entire nucleotide sequences have been determined and an additional 53 25 
partial E2 sequences collected from GenBank.  The sampling dates, ranging from 1959 to 2004, 26 
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and geographic origins for all partial E2 sequences were also collected and recorded (available 1 
online as Table S3).  The 61 E2 sequences were aligned as above resulting in an alignment of 2 
252 nucleotides (both alignments are available from the authors on request). The passage 3 
histories of the viruses from which the E2 gene sequences were derived  are described in 4 
Sammels et al. (1995). 5 
 6 
Estimation of evolutionary rates and population dynamics in RRV.  A Bayesian skyline 7 
coalescent analysis, which depicts changing levels of relative genetic diversity [i.e. the effective 8 
population size (Ne) times the viral generation time (g)] through time using an unconstrained 9 
demographic model (Drummond et al., 2005), was performed on the data set of 61 dated RRV 10 
E2 sequences using BEAST v1.4.8 (Drummond & Rambaut, 2007).  In this analysis, the 11 
sampling dates of the E2 sequences alone provided the necessary calibrations for estimating 12 
the rate of nucleotide substitution in RRV.  The Bayesian skyline analysis was performed using 13 
the most general GTR+Γ4+I model of nucleotide substitution assuming a relaxed molecular 14 
clock with an uncorrelated log-normal rate distribution (Drummond et al., 2006).  Additional 15 
analyses were performed with combinations of nucleotide substitution models (i.e. HKY with or 16 
without site specific rate variation), strict and relaxed clocks, and constrained (i.e. constant) 17 
demographic models to assess the robustness of our results.  All Markov chains were run for 18 
100,000,000 generations and sampled every 1,000 generations with the first 10,000 samples 19 
discarded as burn-in.  Unless otherwise specified, default priors were used for all parameters.  20 
The program Tracer v1.4 (http://evolve.zoo.ox.ac.uk) was used to visually inspect sampled 21 
posterior probabilities for chain stationarity, to calculate summary statistics for genetic 22 
parameters, and to generate Bayesian skyline plots.  Sampling error is represented by values 23 
for the 95% Highest Probability Density (HPD). 24 
 25 
 8
Phylogenetic Analysis of RRV Geographic Structure.  The posterior set of trees was used to 1 
estimate the overall Maximum Clade Credibility (MCC) phylogeny for the E2 sequence data.  To 2 
determine the extent of geographic structure in RRV populations we estimated the strength of 3 
association between phylogenetic relationships and sampling locations.  The degree of 4 
association was estimated using the parsimony score (PS; Slatkin & Maddison, 1989) and 5 
association index (AI; Wang et al., 2001) statistics to determine the association with sampling 6 
locations across the entire tree, and the maximum monophyletic clade size (MC; Parker et al., 7 
2008) statistic to assess the association with particular sampling locations.  Each E2 sequence 8 
was coded as coming from one of five geographic regions: Northeast Australia (Queensland), 9 
Southeast Australia (New South Wales, Tasmania, or Victoria), Western Australia, North Central 10 
Australia (Northern Territory), or Pacific Islands (Cook Islands, Fiji, or Samoa) (see Table S1). 11 
Using the program BaTS v0.90 beta (Parker et al., 2008), distributions of the three statistics 12 
(PS, AI, and MC) were calculated from the posterior samples of trees and compared to null 13 
distributions generated by randomizing the RRV geographic origins and recalculating across the 14 
tree sample to determine the significance of the empirical distributions (Parker et al., 2008).  15 
The first 10,000 sampled trees (i.e. 10%) were discarded as burn-in and 1000 randomizations 16 
were performed to estimate null distributions for the statistics of interest. 17 
 18 
Analysis of Selection Pressures.  A Fixed Effect Likelihood model (FEL; Pond & Frost, 2005c) 19 
was used to determine the strength of selection pressures on the data set of dated E2 20 
sequences, manifest as the ratio of nonsynonymous (dN) to synonymous (dS) substitutions per 21 
site (ratio dN/dS).  The analysis was performed first on all branches of the tree (i.e. FEL) and 22 
subsequently on only internal branches (i.e. IFEL; Pond et al., 2006).  An additional analysis of 23 
selective pressures acting on all genes individually was performed on the coding genome data 24 
using the Single Likelihood Ancestor Counting model (SLAC; Pond & Frost, 2005c).  All 25 
analyses were performed in HyPhy (Pond & Frost, 2005a) on the web server Datamonkey 26 
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(Pond & Frost, 2005b), with all input branch lengths and tree topologies estimated using a 1 
neighbor-joining algorithm and HKY85-based codon substitution model. 2 
 3 
Results and Discussion 4 
The nucleotide sequences of the non-coding regions of RRV, particularly the 5’UTR and the 5 
UTR preceding the structural protein genes, were highly conserved, with only minor variations 6 
found in the human isolate (QML1), and mosquito strains T48 and NB5092.  The 3’ UTR of T48 7 
(mosquito), 2975B, 2982B, 3078B (birds) and QML1 (human) each contained the four repeat 8 
nucleotide sequences described previously (Faragher & Dalgarno, 1986).  Both isolates from 9 
wallabies (8961W and 9057W) had a 35 nucleotide deletion after nucleotide 54 of the 3’UTR 10 
which removed the first 22 nucleotides from repeat sequence III, and which has been described 11 
previously (Faragher & Dalgarno, 1986).  In addition, there were single (T48, 2982) and double 12 
(QML1) nucleotide deletions in the same region (-11 and -11, -12 respectively) of the 23 nt 13 
putative promoter for negative strand RNA synthesis (Kuhn et al., 1990) which immediately 14 
precedes the poly-A tail of the genome.  Finally, the poly-A tail varied in length from 29 (2982B) 15 
to 63 (T48) nucleotides. 16 
 17 
RRV evolutionary rate and population dynamics.  The mean rate of nucleotide substitution 18 
for RRV, calculated using the sampling dates of the partial E2 gene sequences, was 8.08 x 10-4 19 
nucleotide substitutions per site per year (subs/site/year), with a 95% HPD of 3.97 – 12.70 x 10-4 20 
subs/site/year.  Importantly, these results are consistent when estimated using a wide range of 21 
nucleotide substitution, molecular clock, and demographic models (Table 1; complete results of 22 
these analyses, as well as marginal likelihoods, are presented in Table S4).  Our estimate is 23 
consistent both with rate estimates of closely related alphaviruses (e.g. ~1 x 10-3 subs/site/year 24 
for Chikungunya virus; Cherian et al., 2009) and other vector-borne RNA viruses (Hanada et al., 25 
2004; Jenkins et al., 2002).  These results require a reassessment of previous assumptions that 26 
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RRV may evolve slowly (Sammels et al., 1995), and highlight the importance of independent 1 
estimates of substitution rates. 2 
Our coalescent analysis of the 61 partial E2 gene sequences produced a Bayesian 3 
skyline plot, which traces relative genetic diversity through time, revealing that the diversity of 4 
RRV has been remarkably low over time (Figure 1).  Conservatively estimating significant 5 
changes as the occurrence of non-overlapping 95% credible intervals, we saw no significant 6 
changes in the genetic diversity of RRV over time, despite at least one well documented RRV 7 
epidemic (Aaskov et al., 1981; Rosen et al., 1981; Tesh et al.,1981).  This is supported by the 8 
lack of statistical preference for either Bayesian skyline or constant demographic models when 9 
compared to each other (Table 1).  Furthermore, the estimated mean time to the most recent 10 
common ancestor (TMRCA) of the sampled RRV sequences was only 55 years (95% HPD = 45 11 
– 79 years), which is consistent with the low levels of genetic diversity observed in RRV over the 12 
past several decades (reviewed in Russell, 2002).  Together, these results suggest that the 13 
genetic diversity of RRV is, and has been, lower than some other arboviruses, such as the 14 
flaviviruses dengue (Dunham & Holmes, 2007) and yellow fever virus (Bryant et al. 2007), 15 
despite their broadly equivalent rates of nucleotide substitution.  Importantly, the 17D yellow 16 
fever vaccine has retained its efficacy and has not led to antibody escape mutations despite the 17 
greater genetic diversity of yellow fever populations and more than 60 years of use (Barret 18 
1997; Monath 1999).  Interestingly, the genetic diversity of RRV is also slightly lower (although 19 
with overlapping 95% HPDs) to that observed in a closely related alphavirus Chikungunya virus 20 
(Cherian et al., 2009), suggesting that similar mechanisms might underlie both.  Consistent with 21 
this, the TMRCA of the sampled RRV sequences was rather more recent than Chikungunya 22 
virus (55 years for RRV versus 129 years for Chikungunya; Cherian et al. 2009).  This suggests 23 
that either the effective population size of the natural reservoir of RRV is smaller than 24 
Chikungunya, resulting in a more rapid turnover of genetic diversity in RRV by genetic drift, or 25 
that positive selection is driving the more rapid turnover of diversity in RRV. 26 
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 1 
Phylogenetic and Geographic Structure of RRV.  The MCC phylogeny for RRV (Figure 2), 2 
which summarizes the posterior distribution of trees produced from the BEAST analysis, 3 
displays substantial geographic and temporal structure.  Most notably, this tree reveals the 4 
presence of distinct eastern and western Australian RRV lineages (geographic origins identified 5 
by colors), as well as the loss of a northeast Australian lineage.  That the lost lineage has not 6 
been sampled since 1977 and has been replaced in northeast Australia by another lineage 7 
suggests it now is either extinct or has been reduced to a very low frequency in the RRV 8 
population.  The loss of a lineage from a specific geographical distribution without a significant 9 
decrease in the overall genetic diversity of RRV (see Figure 1) suggests that the population 10 
dynamics of RRV may differ between geographic regions.  Furthermore, the basal location of 11 
sequences from northeast Australia (i.e. Queensland), combined with the continued sampling of 12 
RRV in northeast Australia from a single lineage and the relative geographic specificity of the 13 
western Australian lineage, suggests that (i) the present diversity of RRV likely originated in 14 
Queensland, and (ii) most migration of RRV within Australia is from east to west.  Both of these 15 
results support epidemiological data (e.g. higher rates of RRV infection in Queensland than 16 
other Australian provinces; Australian Department of Health and Ageing, 2009) that together 17 
support Queensland as the historical source for RRV in Australia. 18 
Our tests of the association between the geographic origin and phylogenetic 19 
relationships of the sampled RRV sequences revealed significant associations within the tree as 20 
a whole (AI: p < 0.0001; PS: p < 0.0001) and with respect to all geographic regions (MC: 0.03 < 21 
p < 0.001) except the Pacific Islands (MC: p = 1.0).  Hence, clear spatial structure exists within 22 
RRV populations, particularly between eastern and western Australia, confirming the results of 23 
an earlier study of RRV using distance methods (Sammels et al., 1995).  Notably, these results 24 
indicate that the steady accumulation of mutations and high turnover of RRV diversity 25 
(evidenced by the high substitution rate, loss of a lineage, and the recent TMRCA) 26 
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characterized in these analyses are simultaneously occurring in distinct RRV populations not 1 
routinely connected by extensive gene flow.  2 
 3 
Selection Pressures on RRV.  Both natural selection and genetic drift can, individually or in 4 
combination, reduce the genetic diversity within a population.  It is therefore possible that 5 
antigenic drift and recurrent selective sweeps have reduced genetic diversity in RRV 6 
populations.  Strong temporally structured phylogenies such as observed here (Figure 2) are 7 
often the hallmark of continuous selection pressure (Grenfell et al., 2004).  However, the mean 8 
dN/dS ratio in the set of 61 RRV E2 protein sequences analyzed here was 0.25, indicating that 9 
this region is largely evolving under weak purifying selection.  Analyses to determine which, if 10 
any, codons in this region were evolving under positive selection failed to identify any under 11 
models that consider all (FEL; p > 0.05) and only internal (IFEL; p > 0.05) branches.  12 
Furthermore, analysis of the RRV genome data set produced estimates of mean dN/dS for each 13 
gene in the RRV genome (non-structural proteins 1-4, envelope glycoprotein’s 1-3, C protein, 14 
and 6K protein) that supported relatively stronger purifying selection acting across the RRV 15 
genome (0.04 < dN/dS < 0.15), with no sites under significant positive selection (SLAC: p > 16 
0.05). 17 
These signatures of purifying selection are consistent with previous studies 18 
demonstrating constraints on arbovirus evolution produced by simultaneous selection for 19 
replication in two very different hosts (i.e. a range of vertebrate and mosquito hosts; Coffey et 20 
al., 2008; Scott et al., 1994; Woelk & Holmes, 2002).  Importantly, such selective constraints are 21 
expected to limit the coding diversity of RRV and possibly constrain RRV's response to selective 22 
pressures imposed by vaccination of human hosts.  However, it is important to recall the limited 23 
sampling undertaken in this study and its possible effects on the conclusions drawn.  For 24 
example, only five sequences were isolated from the 1979-1980 epidemic of RRV in several 25 
Pacific islands, so that it is difficult to determine whether adaptive evolution occurred during this 26 
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outbreak.  Sampling of RRV more densely in time clearly is required to investigate the 1 
correlation of RRV diversity with historical epidemics in humans (e.g., Aaskov et al., 1981; 2 
Rosen et al., 1981; Tesh et al., 1981), with the general trend of increasing numbers of human 3 
infections (e.g., Boughten et al., 1984; Hawkes et al., 1993; Australian Department of Health 4 
and Ageing 2009), as well as the strength of selection acting on this virus. 5 
Collectively, our findings indicate that whilst RRV is evolving rapidly, its observed genetic 6 
diversity is consistently low through time and has a recent origin.  This is possibly due to 7 
constraints stemming from a life cycle involving replication in distinct hosts and small natural 8 
host populations, rather than antigenic drift or recurrent selective sweeps.  Importantly, it is likely 9 
that these constraints limit the probability that RRV could generate enough antigenic diversity to 10 
escape vaccine-induced immunity.  This is supported by historical observations of life-long 11 
immunity provided by natural RRV infection of humans (Fraser, 1986).  In the absence of 12 
substantial and unforeseen changes in the molecular evolution of RRV, our analyses suggest 13 
that the evolutionary dynamics of RRV do not preclude the success of vaccination in controlling 14 
epidemic polyarthritis. 15 
 16 
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Table 1.  Estimates of substitution rates, time to most recent common ancestor, and marginal 1 
likelihoods estimated from E2 gene sequences 2 
 3 
Nucleotide 
substitution 
model 
Clock model Demographic 
model 
Marginal 
likelihood 
(ln1) 
TMRCA2 
(years) 
Mean substitution 
rate  
(subs/site/year) 
GTR3+Γ44+I5 Relaxed 
(Lognormal) 
Bayesian 
skyline plot 
-647.97 54.5 
(45.0 – 79.0) 
8.13 x 10-4  
(3.87 – 12.6 x 10-4) 
GTR+Γ4+I Strict Bayesian 
skyline plot 
-648.28 53.4 
(45.0 – 70.7) 
8.55 x 10-4  
(4.50 – 12.9 x 10-4) 
GTR+Γ4+I Relaxed 
(Lognormal) 
Constant -649.44 62.4 
(45.0 – 89.2) 
6.91 x 10-4  
(3.44 – 10.9 x 10-4) 
GTR+Γ4+I Strict Constant -650.27 58.8 
(45.0 – 79.9) 
7.45 x 10-4  
(3.85 – 11.4 x 10-4) 
HKY6 Strict Constant -653.09 59.1 
(45.0 – 79.7) 
6.78 x 10-4  
(3.58 – 10.4 x 10-4) 
 4 
1Natural log (ln) of the marginal likelihood 5 
2Time to the Most Recent Common Ancestor (TMRCA) 6 
3General Time Reversible (GTR) nucleotide substitution model with 6 reversible nucleotide 7 
substitution rate categories 8 
4Gamma distribution (Γ) of between nucleotide sites model of substitution rate variation 9 
5Proportion of invariant sites (I) model of substitution rate variation 10 
6Hasegawa-Kishino-Yano (HKY) substitution model with 2 reversible nucleotide substitution rate 11 
categories (transitions and transversions) 12 
13 
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Figure Legends 1 
Figure 1.  Bayesian skyline plot depicting relative genetic diversity through time for 61 dated E2 2 
gene nucleotide sequences.  Time (x-axis) is measured in calendar years, while genetic 3 
diversity (y-axis) is a compound variable relating the effective population size (Ne) and viral 4 
generation time (g).  The black line traces the mean genetic diversity, while the blue lines 5 
indicate 95% credible intervals.  The dotted line indicates the lower 95% credible interval for the 6 
coalescent time of the sampled sequences (which occurs at the right-hand edge of the plot).  7 
Notably, this plot is indicative of no significant changes in RRV genetic diversity from the past to 8 
the present. 9 
 10 
Figure 2.  Maximum Clade Credibility (MCC) phylogeny of 61 dated E2 gene nucleotide 11 
sequences estimated from the posterior distribution of trees produced in the Bayesian skyline 12 
plot coalescent analysis.  The geographic origin of each RRV sequence is indicated by color 13 
[dark blue = Southwest Australia (New South Wales, Tasmania, Victoria); light blue = North 14 
Central Australia (Northern Territory); green = Western Australia; red = Northeast Australia 15 
(Queensland); purple = Pacific Islands (Cook Islands, Samoa, Fiji), and posterior probabilities 16 
for branches receiving at least p = 0.70 support are printed in italics above each branch.  The x-17 
axis is scaled in calendar years.  This phylogeny demonstrates the population structure of RRV 18 
diversity by the presence of geographically distinct viral lineages, as well as the rapid turnover in 19 
diversity of RRV. 20 
 21 
Table S1. Oligonucleotide primers used for PCR and for sequencing of Ross River virus 22 
genomes. 23 
 24 
 21
Table S2.  Isolation and passage information for novel RRV genome sequences.  Strain 1 
identification, year of isolation, isolation source, geographical location, passage history, 2 
publication reference, and GenBank accession numbers are included. 3 
 4 
Table S3.  Sampling Information for the 61 E2 gene sequences used in this study.  GenBank 5 
accession numbers, sampling dates (in years), geographic origins, and publication reference 6 
(unless novel) are included. 7 
 8 
Table S4. Results of Bayesian skyline coalescent analyses of 61 E2 gene sequences using a 9 
range of nucleotide substitution, molecular clock, and demographic models. 10 
 11 
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